Bone marrow transplantation for patients with chronic myeloid leukaemia: T-cell depletion with Campath-1 reduces the incidence of graft-versus-host disease but may increase the risk of leukaemic relapse.
Between December 1983 and November 1985 we treated 39 patients with chronic myeloid leukaemia by chemoradiotherapy and transplantation from HLA-identical sibling donors using bone marrow that had been depleted of T cells ex vivo with the rat monoclonal antibody Campath-1. Twenty-eight of the patient...
Main Authors: | Apperley, J, Jones, L, Hale, G, Waldmann, H, Hows, J, Rombos, Y, Tsatalas, C, Marcus, R, Goolden, A, Gordon-Smith, E |
---|---|
Format: | Journal article |
Language: | English |
Published: |
1986
|
Similar Items
-
Leukaemic relapse after Campath 1-treated bone-marrow transplantation for leukaemia.
by: Waldmann, H, et al.
Published: (1987) -
RESULTS OF T-CELL DEPLETION WITH CAMPATH-1 IN BONE-MARROW TRANSPLANTATION (BMT) FOR CHRONIC GRANULOCYTIC-LEUKEMIA (CGL)
by: Apperley, J, et al.
Published: (1985) -
Bone marrow transplantation for patients with chronic myeloid leukemia.
by: Goldman, J, et al.
Published: (1986) -
REDUCED INCIDENCE OF GVHD IN RECIPIENTS OF T-CELL DEPLETED MARROW
by: Apperley, J, et al.
Published: (1986) -
T cell depletion with CAMPATH-1 in allogeneic bone marrow transplantation.
by: Hale, G, et al.
Published: (1988)